KR102071614B9 - 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물 - Google Patents

6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물

Info

Publication number
KR102071614B9
KR102071614B9 KR20190050324A KR20190050324A KR102071614B9 KR 102071614 B9 KR102071614 B9 KR 102071614B9 KR 20190050324 A KR20190050324 A KR 20190050324A KR 20190050324 A KR20190050324 A KR 20190050324A KR 102071614 B9 KR102071614 B9 KR 102071614B9
Authority
KR
South Korea
Prior art keywords
norleucine
diazo
oxo
treatment
pharmaceutical composition
Prior art date
Application number
KR20190050324A
Other languages
English (en)
Other versions
KR102071614B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to KR1020190050324A priority Critical patent/KR102071614B1/ko
Application granted granted Critical
Publication of KR102071614B1 publication Critical patent/KR102071614B1/ko
Priority to US17/606,790 priority patent/US20220143047A1/en
Priority to PCT/KR2020/005734 priority patent/WO2020222552A1/ko
Priority to EP20797986.5A priority patent/EP3964215A4/en
Priority to CN202080032623.0A priority patent/CN114173790A/zh
Publication of KR102071614B9 publication Critical patent/KR102071614B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020190050324A 2019-04-30 2019-04-30 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물 KR102071614B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020190050324A KR102071614B1 (ko) 2019-04-30 2019-04-30 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물
US17/606,790 US20220143047A1 (en) 2019-04-30 2020-04-29 Pharmaceutical composition comprising 6-diazo-5-oxo-l-norleucine for treating inflammatory skin disease
PCT/KR2020/005734 WO2020222552A1 (ko) 2019-04-30 2020-04-29 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부질환 치료용 약제학적 조성물
EP20797986.5A EP3964215A4 (en) 2019-04-30 2020-04-29 PHARMACEUTICAL COMPOSITION WITH 6-DIAZO-5-OXO-L-NORLEUCINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
CN202080032623.0A CN114173790A (zh) 2019-04-30 2020-04-29 一种包含6-重氮-5-氧代-l-正亮氨酸的用于治疗炎症皮肤疾病的药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190050324A KR102071614B1 (ko) 2019-04-30 2019-04-30 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020190139995A Division KR20200126882A (ko) 2019-11-05 2019-11-05 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물

Publications (2)

Publication Number Publication Date
KR102071614B1 KR102071614B1 (ko) 2020-01-30
KR102071614B9 true KR102071614B9 (ko) 2021-10-27

Family

ID=69321319

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190050324A KR102071614B1 (ko) 2019-04-30 2019-04-30 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물

Country Status (5)

Country Link
US (1) US20220143047A1 (ko)
EP (1) EP3964215A4 (ko)
KR (1) KR102071614B1 (ko)
CN (1) CN114173790A (ko)
WO (1) WO2020222552A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112807297A (zh) * 2021-01-20 2021-05-18 深圳市福田区风湿病专科医院 6-重氮-5-氧代-l-正亮氨酸在制备防治银屑病药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100647857B1 (ko) 2002-06-03 2006-11-23 가부시키가이샤 시에시 피부염 치료용 외용제
US20160022708A1 (en) * 2013-03-14 2016-01-28 St. Jude Children's Research Hospital Methods and compositions for the treatment of glutamine-addicted cancers
WO2014170435A2 (en) * 2013-04-18 2014-10-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for inhibiting lymphocyte proliferation in a subject in need thereof
WO2017023787A1 (en) * 2015-07-31 2017-02-09 The Johns Hopkins University Methods and compositions for treating metabolic reprogramming disorders
CA3025698A1 (en) 2016-06-03 2017-12-07 Avexxin As Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
CN112807297A (zh) * 2021-01-20 2021-05-18 深圳市福田区风湿病专科医院 6-重氮-5-氧代-l-正亮氨酸在制备防治银屑病药物中的应用

Also Published As

Publication number Publication date
KR102071614B1 (ko) 2020-01-30
WO2020222552A1 (ko) 2020-11-05
EP3964215A4 (en) 2023-01-18
US20220143047A1 (en) 2022-05-12
CN114173790A (zh) 2022-03-11
EP3964215A1 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
ZA202007055B (en) Compositions for the treatment of skin conditions
IL275321A (en) Treatment of diseases associated with the expression of DUX4
ZA202006610B (en) Compositions for the treatment of skin conditions
IL287522A (en) Useful preparations for the treatment of Pompe disease
ZA202101587B (en) Protein for treatment of inflammatory diseases
EP3685840A4 (en) PHARMACEUTICAL COMPOSITION OF COMPOUNDS FOR TREATING INFLAMMATORY SKIN DISEASES
IL282643A (en) Soft combinations for the treatment of hematological diseases
IL287802A (en) Preparations and methods for the treatment of eye diseases
ZA202007320B (en) Compounds for pain treatment, compositions comprising same, and methods of using same
PT3684477T (pt) Composições úteis para o tratamento cosmético da pele oleosa
SG11202007082PA (en) Composition used for therapeutic treatment of skin disease
KR102071614B9 (ko) 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물
EP3706867A4 (en) THERAPEUTIC COMBINATION FOR TREATMENT OF CEREBELLIC ATAXIA
EP3565561A4 (en) PHOSPHAPLATIN COMPOUNDS AS THERAPEUTICS FOR THE TREATMENT OF BONE / BLOOD CANCER
GB201805100D0 (en) Treatment of sarcopenic diseases
GB201908076D0 (en) Skin treatment composition
EP4003381A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES
KR102090101B9 (ko) 구강 질환 예방 또는 치료용 조성물
IL276228A (en) Compounds and preparations for the treatment of pain
GB2571170B (en) Cosmetic composition for treatment of keratinous fibers
GB201801466D0 (en) Preparation for treatment of wounds
GB201806663D0 (en) 2-Oxothiazole compositions for treatment of fibrotic disease
EP4003283C0 (en) TREATMENT OF INFLAMMATORY SKIN CONDITIONS
GB201909438D0 (en) Treatment of diseases
IL263336A (en) Compounds for the treatment of symphysiolysis

Legal Events

Date Code Title Description
X091 Application refused [patent]
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]